Literature DB >> 19127360

Effects of e-mails containing ADR information and a current case report on ADR reporting rate and quality of reports.

Marie-Louise Johansson1, Gertrud Brunlöf, Christina Edward, Susanna M Wallerstedt.   

Abstract

BACKGROUND: Spontaneous reporting of adverse drug reactions (ADRs) is one approach to increasing our knowledge on the risks of drugs in clinical practice. Under-reporting is a shortcoming of this system.
OBJECTIVES: To evaluate if repeated e-mails with attachments on ADR information can affect (1) the reporting of ADRs and (2) the quality of the ADR reports.
METHODS: All 117 heads of primary health care units in the region of Västra Götaland in Sweden were randomly allocated (1:1) to an intervention group or a control group. The intervention consisted of e-mails with attachments sent out to each of the 117 heads in January, May and September 2007. These e-mails included (1) the heading "Every ADR report is important", (2) a current case report of an ADR and (3) instructions on how to report. The number of reports from each primary health care unit run by the same head was registered, as was the quality of the report. The quality was defined as high if the ADR was (1) serious, (2) unexpected or (3) related to the use of new drugs and not labeled as common in the summary of product characteristics. All other reports were regarded as low-quality reports.
RESULTS: The total number of reports increased from 89 in 2006 to 111 in 2007 (P = 0.037). No difference in the number of reports between intervention (n = 56) and control (n = 55) units could be detected. The proportion of high-quality reports before and after the intervention was 36 and 48%, respectively (intervention, P = 0.11) and 40 and 36%, respectively (control, P = 0.55).
CONCLUSIONS: No apparent effect of repeated ADR e-mails on the reporting of ADRs could be detected, although an increase in the reporting rate in general was noted.

Mesh:

Year:  2009        PMID: 19127360     DOI: 10.1007/s00228-008-0603-6

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  14 in total

1.  Attitudes to reporting adverse drug reactions in northern Sweden.

Authors:  M Bäckström; T Mjörndal; R Dahlqvist; T Nordkvist-Olsson
Journal:  Eur J Clin Pharmacol       Date:  2000-12       Impact factor: 2.953

2.  Physicians' attitudes and adverse drug reaction reporting : a case-control study in Portugal.

Authors:  Maria T Herdeiro; Adolfo Figueiras; Jorge Polónia; Juan Jesus Gestal-Otero
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

3.  An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial.

Authors:  Adolfo Figueiras; Maria T Herdeiro; Jorge Polónia; Juan Jesus Gestal-Otero
Journal:  JAMA       Date:  2006-09-06       Impact factor: 56.272

4.  Adverse drug reaction reporting by nurses in Sweden.

Authors:  M Bäckström; Elisabet Ekman; T Mjörndal
Journal:  Eur J Clin Pharmacol       Date:  2007-04-03       Impact factor: 2.953

5.  Reporting of adverse drug reactions may be influenced by feedback to the reporting doctor.

Authors:  Susanna M Wallerstedt; Gertrud Brunlöf; Marie-Louise Johansson; Carina Tukukino; Lars Ny
Journal:  Eur J Clin Pharmacol       Date:  2007-03-09       Impact factor: 2.953

6.  Under-reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel system.

Authors:  A Alvarez-Requejo; A Carvajal; B Bégaud; Y Moride; T Vega; L H Arias
Journal:  Eur J Clin Pharmacol       Date:  1998-08       Impact factor: 2.953

7.  Reporting of adverse drug reactions by hospital doctors and the response to intervention.

Authors:  P McGettigan; J Golden; R M Conroy; N Arthur; J Feely
Journal:  Br J Clin Pharmacol       Date:  1997-07       Impact factor: 4.335

8.  Adverse drug events in hospitalized patients. A comparison of doctors, nurses and patients as sources of reports.

Authors:  P M van den Bemt; A C Egberts; A W Lenderink; J M Verzijl; K A Simons; W S van der Pol; H G Leufkens
Journal:  Eur J Clin Pharmacol       Date:  1999-04       Impact factor: 2.953

9.  Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study.

Authors:  Sebastian Schneeweiss; Joerg Hasford; Martin Göttler; Annemarie Hoffmann; Ann-Kathrin Riethling; Jerry Avorn
Journal:  Eur J Clin Pharmacol       Date:  2002-06-12       Impact factor: 2.953

10.  Influence of an e-mail with a drug information attachment on sales of prescribed drugs: a randomized controlled study.

Authors:  Christina Edward; Anders Himmelmann; Susanna M Wallerstedt
Journal:  BMC Clin Pharmacol       Date:  2007-10-18
View more
  6 in total

1.  Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia-Romagna region).

Authors:  Chiara Biagi; Nicola Montanaro; Elena Buccellato; Giuseppe Roberto; Alberto Vaccheri; Domenico Motola
Journal:  Eur J Clin Pharmacol       Date:  2012-06-17       Impact factor: 2.953

Review 2.  Strategies to improve adverse drug reaction reporting: a critical and systematic review.

Authors:  Cristian Gonzalez-Gonzalez; Elena Lopez-Gonzalez; Maria T Herdeiro; Adolfo Figueiras
Journal:  Drug Saf       Date:  2013-05       Impact factor: 5.606

3.  Impact of information letters on the reporting rate of adverse drug reactions and the quality of the reports: a randomized controlled study.

Authors:  Marie-Louise Johansson; Staffan Hägg; Susanna M Wallerstedt
Journal:  BMC Clin Pharmacol       Date:  2011-09-07

Review 4.  How to promote adverse drug reaction reports using information systems - a systematic review and meta-analysis.

Authors:  Inês Ribeiro-Vaz; Ana-Marta Silva; Cristina Costa Santos; Ricardo Cruz-Correia
Journal:  BMC Med Inform Decis Mak       Date:  2016-03-01       Impact factor: 2.796

Review 5.  A narrative review of evidence to guide deprescribing among older adults.

Authors:  Kenya Ie; Shuichi Aoshima; Taku Yabuki; Steven M Albert
Journal:  J Gen Fam Med       Date:  2021-05-28

6.  Promoting adverse drug reaction reporting: comparison of different approaches.

Authors:  Inês Ribeiro-Vaz; Cristina Costa Santos; Ricardo Cruz-Correia
Journal:  Rev Saude Publica       Date:  2016-05-03       Impact factor: 2.106

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.